GLP-1 Eligibility Guide: Who Can Use & Benefits

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed how millions manage weight and blood sugar, with clinical trials showing 15-22% body weight reduction over 68 weeks. Understanding whether you qualify for this therapy—and which formulation fits your lifestyle—is the first step toward lasting metabolic change.

Who Is Eligible for GLP-1 Therapy?

GLP-1 medications are available to adults across all 50 states through PlexusDx without requiring a pre-existing diagnosis or insurance approval. Candidacy typically includes individuals with a BMI of 25 or higher, or those managing weight-related metabolic conditions. PlexusDx evaluates your health history through a simple intake questionnaire to ensure safe, personalized dosing protocols suited to your individual metabolism.

Unlike traditional medical settings, PlexusDx removes barriers to access—no membership fees, no insurance requirement, and HSA/FSA eligibility for those with compatible accounts. The company works with licensed 503A compounding pharmacies to deliver medications to your home, making treatment initiation as simple as answering screening questions and connecting with a provider.

How GLP-1 Medications Work for Weight Loss

GLP-1 receptor agonists mimic a natural gut hormone that signals fullness to your brain, reduces appetite hormones like ghrelin, and slows stomach emptying. This triple mechanism leads to sustained calorie reduction without requiring extreme dietary willpower. PlexusDx offers both injected and oral formulations—Semaglutide Injection starting at $149/mo, and Oral Semaglutide at $249/mo—so you can choose the delivery method that fits your routine.

Clinical data demonstrates that GLP-1 users lose weight consistently over 12-24 months and maintain results better than with diet and exercise alone. The medications also improve fasting blood glucose, reduce cardiovascular risk markers, and decrease inflammation. PlexusDx's Precision Peptide Genetic Test identifies your peptide-pathway variants to optimize which compound—Semaglutide, Tirzepatide, or a dual-compound protocol—will work best for your genetic profile.

Medical Conditions That Benefit from GLP-1 Treatment

Beyond weight loss, GLP-1 therapy reduces heart attack and stroke risk in patients with type 2 diabetes or established cardiovascular disease. The medications also lower A1C levels, reduce liver fat in non-alcoholic fatty liver disease, and decrease inflammation markers linked to chronic disease. PlexusDx providers evaluate your full metabolic picture—not just weight—to determine if GLP-1 aligns with your long-term health goals.

Individuals with prediabetes, metabolic syndrome, polycystic ovary syndrome (PCOS), and obesity-related joint strain also benefit from the metabolic reset GLP-1 provides. Your PlexusDx provider will review your lab history and family disease risk to confirm whether GLP-1 addresses your specific health drivers, ensuring treatment targets the root cause rather than the symptom.

GLP-1 Eligibility Exclusions and Safety Considerations

GLP-1 medications are not recommended for individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe pancreatitis. Pregnant or breastfeeding individuals should not use GLP-1 due to limited safety data, and patients with diabetic retinopathy requiring insulin may need dose adjustments. PlexusDx's intake process screens for these contraindications to ensure safe, appropriate candidacy before treatment begins.

Common side effects like nausea, vomiting, and constipation typically decrease after the first 2-4 weeks as your body adjusts to the medication. Serious adverse events are rare at therapeutic doses, and PlexusDx provides ongoing monitoring and side-effect management through your provider. Your dose may increase as your body adapts—your price won't, keeping treatment affordable throughout your entire therapy timeline.

Choosing Your GLP-1 Treatment Plan at PlexusDx

PlexusDx offers multiple GLP-1 formulations to match your preferences and metabolic needs. Semaglutide Injection ($149/mo), Oral Semaglutide ($249/mo), Tirzepatide Injection ($249/mo), Oral Tirzepatide ($279/mo), and combination protocols like GLP-Squared (dual Semaglutide + Tirzepatide) accommodate different patient priorities. The Microdose GLP-1 Protocol starts at $129/mo for those seeking a gentler entry into peptide therapy.

Adding the Precision Peptide Genetic Test ($99 add-on after your first month) reveals your genetic predispositions across 14 metabolic pathways and 150+ insights, helping your provider fine-tune your compound and dose strategy. This test analyzes key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 to predict which therapy will drive your best outcomes. PlexusDx's data-driven approach transforms GLP-1 from a one-size-fits-all medication into a truly personalized treatment aligned with your biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need to have diabetes or a specific disease to qualify for GLP-1 at PlexusDx?

No. PlexusDx serves adults seeking weight loss and metabolic optimization across all 50 states without requiring a diabetes diagnosis. Your eligibility is based on BMI, metabolic history, and health goals evaluated during intake. PlexusDx providers can confirm candidacy in minutes.

What is the clinical evidence that GLP-1 actually works for weight loss?

Landmark clinical trials show GLP-1 users lose 15-22% of body weight over 68 weeks, compared to 2-3% with lifestyle changes alone. Studies also demonstrate improved blood sugar control, reduced cardiovascular events, and sustained weight maintenance for years. PlexusDx uses these evidence-based compounds from licensed 503A compounding pharmacies...

How much does GLP-1 therapy cost with PlexusDx?

Semaglutide Injection starts at $149/mo, Oral Semaglutide at $249/mo, and Tirzepatide options range from $249-$279/mo depending on formulation. PlexusDx pricing is flat per compound regardless of your dose level—your dose may increase over time, but your monthly cost stays the same. All plans are HSA/FSA eligible, and there are no membership fee...

What are the most common side effects, and how long do they last?

Nausea, vomiting, and constipation occur in 30-50% of patients during the first 2-4 weeks, then typically resolve as your body adapts. Serious side effects are rare at therapeutic doses. PlexusDx provides ongoing monitoring and can adjust your protocol or recommend side-effect management strategies to keep you comfortable throughout treatment.

How does the Precision Peptide Genetic Test help personalize my GLP-1 therapy?

PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes 14 metabolic pathways and 150+ genetic insights to reveal which GLP-1 compound and dose strategy will work best for your biology. Testing variants like GLP1R and GIPR helps predict responder status, while FTO and MC4R data optimize your overall metabolic programming. This genetic bl...

Can Anyone Get GLP-1? Understanding Eligibility and Benefits of GLP-1 Medications